Fundamental considerations in the design of fluorine-18 labeled progestins and androgens as imaging agents for receptor-positive tumors of the breast and prostate
- PMID: 3280523
- DOI: 10.1016/0883-2897(88)90162-6
Fundamental considerations in the design of fluorine-18 labeled progestins and androgens as imaging agents for receptor-positive tumors of the breast and prostate
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical